维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Kelaidi"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The hrpZ gene of Pseudomonas syringae pvphaseolicola enhances resistance to rhizomania disease in transgenic Nicotiana benthamiana and sugar beet显示文摘	Pavli O I Kelaidi G I Tampakaki A P	2011	PLoS One2011，6，3：	1
	2	Response to antiviral treatment in hepatitis C virusassociated marginal zone lymphomas显示文摘	Kelaidi C Rollot F Park S	2004	Leukemia2004，18，10：	1
	3	Late first relapse in APL treated with all-retinoic acid-and anthracycline-based chemotherapy,the European APL group experience (APL 91 and APL 93 trials) 显示文摘	Kelaidi C Ades L Chevret S	2006	Leukemia2006，20，5：	1
	4	Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years:the European APL Group expedence显示文摘	Kelaidi C Chevret S De Botton S	2009	J Clin Oncol2009，27，16：	1
	5	Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF:the GFM experience显示文摘	Park S Grabar S Kelaidi C	2008	Blood2008，111，：	1
	6	Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience显示文摘	PARK S GRABAR S KELAIDI C	2008	Blood2008，111，：	1
	7	hnproved outcome of acute proruyelocytic leukemia with high WBC counts over the last 15 years : the European APL Group experience 显示文摘	Kelaidi C Chevret S De Botton S	2009	J Clin Oncol2009，27，16：	1
	8	Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents显示文摘	Kelaidi C Park S Sapena R	2013	Leukemia2013，27，：	1
	9	Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion:a retro- spective analysis on 112 patients 显示文摘	Park S Kelaidi C Sapena R	2010	Leuk Res2010，34，11：	1
	10	Daily practice management of myelodysplastic syndromes in France: Results of a oneweek crosssectional study in 907 patients by the Groupe Francophone des Myelodysplasies 显示文摘	Kelaidi C Stanmtoullas A Beyne-Rauzy O	2009	Hacmatologica2009，95，：	1
	11	Treatment of acute promyelocytic leukemia with high white cell blood counts显示文摘	Kelaidi C Ades L Fenaux P		0，，01：	1
	12	Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years:the European APL Group experience显示文摘	Kelaidi C Chevret S De Botton S	2009	J Clin Oncol2009，27，16：	1
	13	When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group)显示文摘	Cassinat B de Botton S Kelaidi C	2009	Leuk Res2009，33，9：	1
	14	Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients显示文摘	Eirini Katodritou Evangelos Terpos Argiris S. Symeonidis Anastasia Pouli Charikleia Kelaidi Marie‐Christine Kyrtsonis Maria Kotsopoulou Sosana Delimpasi Anna Christoforidou Nikolaos Giannakoulas Nora‐Athina Viniou Ekaterini Stefanoudaki Christina Hadjiagg	2014	Am. J. Hematol2014，，8：	1
	15	Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion:a retrospective analysis on 112 patients显示文摘	Park S Kelaidi C Sapena R		0，，11：	1
	16	Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas显示文摘	Kelaidi C Rollot F Park S	2004	Leukemia2004，18，：	1
	17	Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoie- tin and G-CSF : The GFM experience 显示文摘	Park S Grabar S Kelaidi C	2008	Blood2008，111，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费